---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-005233"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2026-07-02T11:30:21+00:00"
generated_at: "2026-07-02T11:35:09.438372+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CNS Pharmaceuticals posts investor presentation; no new material details disclosed

## Summary
- Investor presentation posted on company website on July 2, 2026.
- Filing includes only cover page and forward-looking statements; no financial or operational data.
- No updates on clinical trials, revenue, or guidance provided in this filing.
- Full presentation available on company's website.

## SEC filing metadata
- accession: 0001683168-26-005233
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2026-07-02T11:30:21+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316826005233/0001683168-26-005233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316826005233/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-005233
- JSON: https://secwatch.observer/filing/0001683168-26-005233.json
- Plain text: https://secwatch.observer/filing/0001683168-26-005233.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.